NOTCH1, SF3B1, BIRC3 and TP53 mutations in patients with chronic lymphocytic leukemia undergoing first-line treatment: correlation with biological parameters and response to treatment. (Q52648282)

From Wikidata

Jump to navigation Jump to search

scientific article published in December 2014

Language	Label	Description	Also known as
English	NOTCH1, SF3B1, BIRC3 and TP53 mutations in patients with chronic lymphocytic leukemia undergoing first-line treatment: correlation with biological parameters and response to treatment.	scientific article published in December 2014

Statements

scholarly article

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/24597984

NOTCH1, SF3B1, BIRC3 and TP53 mutations in patients with chronic lymphocytic leukemia undergoing first-line treatment: correlation with biological parameters and response to treatment. (English)

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/24597984

0 references

1 reference

based on heuristic

inferred from title

chronic lymphocytic leukemia

1 reference

based on heuristic

inferred from title

6

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/24597984

Francesca Romana Mauro

10

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/24597984

13

object named as

Robin Foà

1 reference

Europe PubMed Central

5 May 2018

Gianluca Gaidano

12

object named as

Gianluca Gaidano

1 reference

Europe PubMed Central

5 May 2018

Sabina Chiaretti

1

object named as

Sabina Chiaretti

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/24597984

Alfonso Piciocchi

5

object named as

Alfonso Piciocchi

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/24597984

Ilaria Del Giudice

3

object named as

Ilaria Del Giudice

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/24597984

Marilisa Marinelli

2

object named as

Marilisa Marinelli

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/24597984

11

object named as

Anna Guarini

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/24597984

7

object named as

Marco Vignetti

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/24597984

4

object named as

Silvia Bonina

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/24597984

Valeria Di Maio

9

object named as

Valeria Di Maio

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/24597984

author name string

Davide Rossi

8

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/24597984

publication date

1 December 2014

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/24597984

Leukemia & Lymphoma

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/24597984

55

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/24597984

2785-2792

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/24597984

12

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/24597984

CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

The prognostic value of CD38 expression in chronic lymphocytic leukaemia patients studied prospectively at diagnosis: a single institute experience.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

Genomic aberrations and survival in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

Subcutaneous alemtuzumab in fludarabine-refractory chronic lymphocytic leukemia: clinical results and prognostic marker analyses from the CLL2H study of the German Chronic Lymphocytic Leukemia Study Group

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

NOTCH1 mutations in CLL associated with trisomy 12.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

NOTCH1 mutations in +12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of +12 CLL

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

SF3B1 and other novel cancer genes in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

Clinical implications of the molecular genetics of chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

NOTCH1, SF3B1, and TP53 mutations in fludarabine-refractory CLL patients treated with alemtuzumab: results from the CLL2H trial of the GCLLSG.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

White blood cell count at diagnosis and immunoglobulin variable region gene mutations are independent predictors of treatment-free survival in young patients with stage A chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

Mutational status of the TP53 gene as a predictor of response and survival in patients with chronic lymphocytic leukemia: results from the LRF CLL4 trial

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

TP53 mutation and survival in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

The prognostic value of TP53 mutations in chronic lymphocytic leukemia is independent of Del17p13: implications for overall survival and chemorefractoriness.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

ATM gene alterations in chronic lymphocytic leukemia patients induce a distinct gene expression profile and predict disease progression

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

TP53, SF3B1, and NOTCH1 mutations and outcome of allotransplantation for chronic lymphocytic leukemia: six-year follow-up of the GCLLSG CLL3X trial.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

ERIC recommendations on IGHV gene mutational status analysis in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

Identifiers

10.3109/10428194.2014.898760

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/24597984

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/24597984

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52648282&oldid=1846274615"